IRW-PRESS: Gemoscan Canada Inc.: Bodybliss und Gemoscan werden Partner in der Behandlung von Nahrun - 500 Beiträge pro Seite | Diskussion im Forum
eröffnet am 10.12.12 10:50:36 von
neuester Beitrag 20.11.13 18:04:39 von
neuester Beitrag 20.11.13 18:04:39 von
Beiträge: 19
ID: 1.178.247
ID: 1.178.247
Aufrufe heute: 0
Gesamt: 2.612
Gesamt: 2.612
Aktive User: 0
ISIN: CA36866N1069 · WKN: A1C9EY
0,0010
EUR
0,00 %
0,0000 EUR
Letzter Kurs 11.01.16 Frankfurt
Werte aus der Branche Gesundheitswesen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 4,9700 | +324,79 | |
| 1,7400 | +74,00 | |
| 17,070 | +55,18 | |
| 0,7975 | +45,00 | |
| 3,0900 | +25,61 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 5,3200 | -13,92 | |
| 1,7500 | -14,22 | |
| 0,5105 | -14,37 | |
| 1,9300 | -15,72 | |
| 1,8819 | -55,93 |
Feedback
Bodybliss und Gemoscan werden Partner in der Behandlung von Nahrungsmittelunverträglichkeiten von Millionen FilipinosDas HEMOCODE™ Food Intolerance System ist für Filipino-Kunden jetzt noch leichter erhältlichBodybliss, die führende Kette von …
Lesen sie den ganzen Artikel: IRW-PRESS: Gemoscan Canada Inc.: Bodybliss und Gemoscan werden Partner in der Behandlung von Nahrungsmittelunverträglichkeiten von Millionen Filipinos
Lesen sie den ganzen Artikel: IRW-PRESS: Gemoscan Canada Inc.: Bodybliss und Gemoscan werden Partner in der Behandlung von Nahrungsmittelunverträglichkeiten von Millionen Filipinos
auch diese poitive meldung verpufft,das einzige gute ist,das es weitergeht,dann hoffen wir mal auf die filipinos,
auch diese positive meldung verpufft,dann hoffen mir mal auf die filipinos,das sie das produkt annehmen
Mit 294.000 Stücken Umsatz auf 0,085 CAD . DAS sieht ja mal ganz gut aus 
Stormy
Stormy
gemoscan wurde schon letztes jahr von einen boersenbrief ganz schön hochgepusht sogar als teenbagger angekündig mit gewaltigen potzenzial,mann sieht was daraus wurde,wie heiße kartoffeln fallen gelassen 
bin leider auch auch auf die Abzocker rein gefallen
Zitat von Stormwind: Mit 294.000 Stücken Umsatz auf 0,085 CAD . DAS sieht ja mal ganz gut aus
Stormy
Kommt dabei wohl stark auf deinen Einstand an.
Aufgeben würde ich die Hoffnung aber auch noch nicht ganz. Bin z.Z. draußen.
Es war eine schöne Sauerei. Wenn alles nur halbwegs so gelaufen wäre, wie großartig von Tim R. angekündigt, dann hätten wir hier aber andere Kurse.
Ein paar Erfolge werden gefeiert, der Rest wird aus dem Musterdepot gefeuert. Und zwar sang- und klanglos.
Die Einen kassieren sowieso ihr Geld, die Anderen müssen hoffen, neben den Abogebühren nicht auch noch den Einsatz zu verlieren.
News News News .........wächst und wächst w
TORONTO, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") – (TSX-V:GES) (MUN:1GE) wishes to announce that it has entered into a letter of intent to undertake a two stage transaction resulting in the Corporation acquiring a 100% interest in Physiomed Yorkdale Inc. ("PYI") which operates a paramedical clinic in Toronto Ontario (the "Acquisition").
Pursuant to the first phase of the acquisition, the Corporation will enter into an agreement, with the shareholders of PYI (the "Vendors"), to manage the operation of the PYI business, for the Corporation's own account ("Management Contract"). In consideration for the Management Contract and the acquisition of $164,000, owed to the Vendors of PYI, (the "Debt"), the Corporation will pay the Vendors $164,000 by way of shares of Gemoscan, to be priced on the closing of the acquisition of the Management Contract and the Debt. The entering into of the Management Contract is expected to close by November 30, 2013 (the "Initial Close").
Gemoscan shall further acquire all of the shares of PYI. The purchase price of the shares of PYI will be calculated based on 5 times the audited annualized net cash flow of PYI from the Initial Close to not later than March 31, 2015. The acquisition of the shares of PYI is expected to close, at Gemoscan's discretion, on or before May 31, 2015 (the "Second Close"). The consideration for the shares of PYI is to be paid as 40% cash, 37% pursuant to a vendor take back mortgage (the "VTB") and 23% either in cash or in shares of Gemoscan priced upon the determination of the purchase price. The VTB shall bear interest at the rate of 7% per annum and shall have a term of 24 months from the Second Close. Interest shall be paid monthly but no principal payments are required until the due date.
Completion of the transactions contemplated herein are conditional on the negotiation of definitive agreements between the parties and the receipt of all applicable regulatory and shareholder approvals including the approval of the TSX Venture Exchange.
"We continue to see tremendous value in the paramedical clinic market. Physiomed Yorkdale; Physiomed Kennedy, acquired in August of this year; and other similar businesses, represent immediately accretive sales engines for Gemoscan, while functioning as organic distribution channels for our patented and proprietary medically supervised diet and wellness programs. Physiomed Yorkdale is yet another stepping stone towards our stated objective of becoming a leading platform in the multibillion dollar retail healthcare space," said Brian Kalish, Gemoscan's CEO.
Scott Wilson, a director of Gemoscan, owns one-third of the shares of PYI through a related company. He owns not more than 42.4% of the Debt that is being transferred to Gemoscan at the Initial Close. As a result, the transactions described herein are related party transactions as such term is defined in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The acquisition of the Debt and the entering into of the management contract by the Corporation is exempt from the valuation and minority shareholder approval requirements of MI 61-101 by reason of the exemptions contained in sections 5.5(a) and 5.7(1)(a) as the total consideration being received by Mr. Wilson does not exceed 25% of Gemoscan's market capitalization. With respect to the acquisition of the shares of PYI, the Corporation will assess its obligations under MI 61-101 once the purchase price has been determined.
About Gemoscan Canada, Inc.
Gemoscan is an industry leader in food intolerance management and maintains a first-to-market position with Canada wide distribution through select retail partners. Founded in 2003, using its proprietary patented technology, Gemoscan develops, owns and markets comprehensive food sensitivity and dietary management solutions for consumers, including the HEMOCODE™ Food Intolerance System and the MenuWise™ Food Intolerance Plan, personalized naturopathically supervised nutritional programs that promote well-being. Gemoscan is the first and only provider to commercialize a food intolerance management solution directly to consumers in partnership with retailers, and today offers the most comprehensive services available. Gemoscan also owns and operates Physiomed Kennedy Inc., a multidisciplinary paramedical clinic, located in Toronto, Ontario.
Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock Exchanges under the symbol 1GE.
Forward-Looking Information
This news release contains certain "forward-looking information". All statements, other than statements of historical fact that address activities, events or developments that Gemoscan believes, expects or anticipates will or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan based on information currently available to Gemoscan. Forward - looking statements are subject to a number of signify cant risks and uncertainties and other factors that may cause the actual results of Gemoscan to differ materially from those discussed in the forward- looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Gemoscan. Any forward -looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Gemoscan disclaims any intent or obligation to update any forward - looking statement, whether as a result of new information, future events or results or otherwise. Although Gemoscan believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CONTACT: Brian Kalish
Chief Executive Officer
Gemoscan Canada, Inc.
416.650.1200
bkalish@hemocode.com
www.gemoscan.com
TORONTO, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") – (TSX-V:GES) (MUN:1GE) wishes to announce that it has entered into a letter of intent to undertake a two stage transaction resulting in the Corporation acquiring a 100% interest in Physiomed Yorkdale Inc. ("PYI") which operates a paramedical clinic in Toronto Ontario (the "Acquisition").
Pursuant to the first phase of the acquisition, the Corporation will enter into an agreement, with the shareholders of PYI (the "Vendors"), to manage the operation of the PYI business, for the Corporation's own account ("Management Contract"). In consideration for the Management Contract and the acquisition of $164,000, owed to the Vendors of PYI, (the "Debt"), the Corporation will pay the Vendors $164,000 by way of shares of Gemoscan, to be priced on the closing of the acquisition of the Management Contract and the Debt. The entering into of the Management Contract is expected to close by November 30, 2013 (the "Initial Close").
Gemoscan shall further acquire all of the shares of PYI. The purchase price of the shares of PYI will be calculated based on 5 times the audited annualized net cash flow of PYI from the Initial Close to not later than March 31, 2015. The acquisition of the shares of PYI is expected to close, at Gemoscan's discretion, on or before May 31, 2015 (the "Second Close"). The consideration for the shares of PYI is to be paid as 40% cash, 37% pursuant to a vendor take back mortgage (the "VTB") and 23% either in cash or in shares of Gemoscan priced upon the determination of the purchase price. The VTB shall bear interest at the rate of 7% per annum and shall have a term of 24 months from the Second Close. Interest shall be paid monthly but no principal payments are required until the due date.
Completion of the transactions contemplated herein are conditional on the negotiation of definitive agreements between the parties and the receipt of all applicable regulatory and shareholder approvals including the approval of the TSX Venture Exchange.
"We continue to see tremendous value in the paramedical clinic market. Physiomed Yorkdale; Physiomed Kennedy, acquired in August of this year; and other similar businesses, represent immediately accretive sales engines for Gemoscan, while functioning as organic distribution channels for our patented and proprietary medically supervised diet and wellness programs. Physiomed Yorkdale is yet another stepping stone towards our stated objective of becoming a leading platform in the multibillion dollar retail healthcare space," said Brian Kalish, Gemoscan's CEO.
Scott Wilson, a director of Gemoscan, owns one-third of the shares of PYI through a related company. He owns not more than 42.4% of the Debt that is being transferred to Gemoscan at the Initial Close. As a result, the transactions described herein are related party transactions as such term is defined in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The acquisition of the Debt and the entering into of the management contract by the Corporation is exempt from the valuation and minority shareholder approval requirements of MI 61-101 by reason of the exemptions contained in sections 5.5(a) and 5.7(1)(a) as the total consideration being received by Mr. Wilson does not exceed 25% of Gemoscan's market capitalization. With respect to the acquisition of the shares of PYI, the Corporation will assess its obligations under MI 61-101 once the purchase price has been determined.
About Gemoscan Canada, Inc.
Gemoscan is an industry leader in food intolerance management and maintains a first-to-market position with Canada wide distribution through select retail partners. Founded in 2003, using its proprietary patented technology, Gemoscan develops, owns and markets comprehensive food sensitivity and dietary management solutions for consumers, including the HEMOCODE™ Food Intolerance System and the MenuWise™ Food Intolerance Plan, personalized naturopathically supervised nutritional programs that promote well-being. Gemoscan is the first and only provider to commercialize a food intolerance management solution directly to consumers in partnership with retailers, and today offers the most comprehensive services available. Gemoscan also owns and operates Physiomed Kennedy Inc., a multidisciplinary paramedical clinic, located in Toronto, Ontario.
Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock Exchanges under the symbol 1GE.
Forward-Looking Information
This news release contains certain "forward-looking information". All statements, other than statements of historical fact that address activities, events or developments that Gemoscan believes, expects or anticipates will or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan based on information currently available to Gemoscan. Forward - looking statements are subject to a number of signify cant risks and uncertainties and other factors that may cause the actual results of Gemoscan to differ materially from those discussed in the forward- looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Gemoscan. Any forward -looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Gemoscan disclaims any intent or obligation to update any forward - looking statement, whether as a result of new information, future events or results or otherwise. Although Gemoscan believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CONTACT: Brian Kalish
Chief Executive Officer
Gemoscan Canada, Inc.
416.650.1200
bkalish@hemocode.com
www.gemoscan.com
Bei Fresenius klappt das auch mit dem Kauf der Kliniken .....
Fresenius ist wohl eine andere nummer wie dieser schrottladen
Canadians leaving extended health benefits unclaimed
Health scores improved, drug claims fell after insurance company adopts wellness strategy
http://myemail.constantcontact.com/Reminder--Don-t-Forget-To…
Health scores improved, drug claims fell after insurance company adopts wellness strategy
http://myemail.constantcontact.com/Reminder--Don-t-Forget-To…
0,09 CAD. Hoffentlich hält das ...
Na klasse , wird ja immer besser mit dem. Laden !!!
Die sollten mal ihren eigenen Aktionärsbrief lesen !!
Die sollten mal ihren eigenen Aktionärsbrief lesen !!
TORONTO!(July!9,!2012)!–!From!weight!gain!to!IBS!to!general!discomfort,!people!are!accepting!the! connection!between!our!overall!well<being!and!the!food!we!eat.!As!a!result!complementary!healthcare! resources!such!as!Canada’s!HEMOCODETM!Food!Intolerance!System!have!been!embraced!and!are! increasing!in!their!accessibility.!!
! Physiomed,!one!of!Canada’s!largest!and!fastest<growing!network!of!healthcare!clinics,!has!recognized!the! need!to!now!incorporate!diet!based!wellness!into!its!collective!approach!to!leading!health!care!solutions! and!is!proud!to!now!provide!the!HEMOCODETM!Food!Intolerance!Testing!System!at!select!locations.!!
! Physiomed!clinics!focus!on!the!treatment,!physical!conditioning,!and!education!of!Canadians!to!promote! long<term!health,!and!believe!that!the!nutritional!wellness!driven!by!HEMOCODETM!is!an!important!tool! and!possible!first!step!in!maintaining!and!managing!specific!and!overall!wellness.!!
! “I!have!been!an!advisor!to!Gemoscan!Canada,!Inc.,!the!company!that!owns!Hemocode,!since!2006!and!a!
Director!of!the!Board!since!2010”!said!Dr.!Scott!Wilson,!DC!;!Founder!and!CEO!of!Physiomed.!!Lately!and! increasingly!I!find!that!the!issues!faced!by!our!growing!patient!base!would!undoubtedly!benefit!from!the! kind!of!comprehensive!approach!to!diet<based!wellness!that!only!Hemocode!can!provide.!!The!time!is! now!right!for!Hemocode!at!Physiomed”.!
!
With!the!spotlight!currently!on!health!crises!such!as!the!obesity!epidemic,!it’s!becoming!clear!that!new! and!more!far<reaching!healthcare!options!must!be!considered!alongside!traditional!western!medicine.! New!research!from!the!University!of!Miami!Miller!School!of!Medicine!and!Zhengzhou!University!in!China,! suggests!that!understanding!individual!reactions!to!specific!foods!is!an!essential!part!of!maintaining!a! healthy!lifestyle!and!potentially!managing!obesity!and!irritable!bowel!syndrome.!
!
“There!is!a!definite!spike!in!the!number!of!health!care!practitioners!and!clinics!that!offer!the!nutritional! wellness!benefits!of!Hemocode!as!a!mainstay!of!an!overall!routine!for!well<being,”!said!Brian!Kalish,!CEO! Gemoscan,!Inc.!“We!are!thrilled!that!Physiomed!is!working!closely!with!us!to!bring!Hemocode,!Canada’s! most!complete!diet!and!nutritional!based!wellness!system!to!its!patients.”!!
! Under!the!supervision!by!Naturopathic!Doctors,!the!HEMOCODETM!Food!Intolerance!System!not!only!aids! in!the!management!of!potentially,!physically!reactive!foods,!but!also!provides!personalized!dietary! guidelines!that!include!replacement!foods,!personalized!recipes!chosen!to!compliment!acceptable!foods,! a!list!of!daily!recommended!vitamins!and!supplements!based!on!personal!reports,!to!help!during!each! step!of!the!food!intolerance!and!nutritional!management!process;!making!HEMOCODETM!the!most! comprehensive!approach!to!the!management!of!food!sensitivities!available!to!consumers!in!the!market! today.!!HEMOCODETM!may!also!be!covered!by!many!extended!insurance!plans!if!individuals!have! extended!health!benefits!that!include!naturopathy.!
!
**For%immediate%release**% HEALTHCARE%LEADER%PHYSIOMED%IDENTIFIES%THE%NEED%FOR%HEMOCODETM%%
HEMOCODE!TM%NOW%AVAILABLE%AT%SELECT%PHYSIOMED%LOCATIONS%
!
! Physiomed,!one!of!Canada’s!largest!and!fastest<growing!network!of!healthcare!clinics,!has!recognized!the! need!to!now!incorporate!diet!based!wellness!into!its!collective!approach!to!leading!health!care!solutions! and!is!proud!to!now!provide!the!HEMOCODETM!Food!Intolerance!Testing!System!at!select!locations.!!
! Physiomed!clinics!focus!on!the!treatment,!physical!conditioning,!and!education!of!Canadians!to!promote! long<term!health,!and!believe!that!the!nutritional!wellness!driven!by!HEMOCODETM!is!an!important!tool! and!possible!first!step!in!maintaining!and!managing!specific!and!overall!wellness.!!
! “I!have!been!an!advisor!to!Gemoscan!Canada,!Inc.,!the!company!that!owns!Hemocode,!since!2006!and!a!
Director!of!the!Board!since!2010”!said!Dr.!Scott!Wilson,!DC!;!Founder!and!CEO!of!Physiomed.!!Lately!and! increasingly!I!find!that!the!issues!faced!by!our!growing!patient!base!would!undoubtedly!benefit!from!the! kind!of!comprehensive!approach!to!diet<based!wellness!that!only!Hemocode!can!provide.!!The!time!is! now!right!for!Hemocode!at!Physiomed”.!
!
With!the!spotlight!currently!on!health!crises!such!as!the!obesity!epidemic,!it’s!becoming!clear!that!new! and!more!far<reaching!healthcare!options!must!be!considered!alongside!traditional!western!medicine.! New!research!from!the!University!of!Miami!Miller!School!of!Medicine!and!Zhengzhou!University!in!China,! suggests!that!understanding!individual!reactions!to!specific!foods!is!an!essential!part!of!maintaining!a! healthy!lifestyle!and!potentially!managing!obesity!and!irritable!bowel!syndrome.!
!
“There!is!a!definite!spike!in!the!number!of!health!care!practitioners!and!clinics!that!offer!the!nutritional! wellness!benefits!of!Hemocode!as!a!mainstay!of!an!overall!routine!for!well<being,”!said!Brian!Kalish,!CEO! Gemoscan,!Inc.!“We!are!thrilled!that!Physiomed!is!working!closely!with!us!to!bring!Hemocode,!Canada’s! most!complete!diet!and!nutritional!based!wellness!system!to!its!patients.”!!
! Under!the!supervision!by!Naturopathic!Doctors,!the!HEMOCODETM!Food!Intolerance!System!not!only!aids! in!the!management!of!potentially,!physically!reactive!foods,!but!also!provides!personalized!dietary! guidelines!that!include!replacement!foods,!personalized!recipes!chosen!to!compliment!acceptable!foods,! a!list!of!daily!recommended!vitamins!and!supplements!based!on!personal!reports,!to!help!during!each! step!of!the!food!intolerance!and!nutritional!management!process;!making!HEMOCODETM!the!most! comprehensive!approach!to!the!management!of!food!sensitivities!available!to!consumers!in!the!market! today.!!HEMOCODETM!may!also!be!covered!by!many!extended!insurance!plans!if!individuals!have! extended!health!benefits!that!include!naturopathy.!
!
**For%immediate%release**% HEALTHCARE%LEADER%PHYSIOMED%IDENTIFIES%THE%NEED%FOR%HEMOCODETM%%
HEMOCODE!TM%NOW%AVAILABLE%AT%SELECT%PHYSIOMED%LOCATIONS%
!
Ich hoffe das sie dann auch mal entsprechend den Umsatz ankurbeln . Da sie ja auch dann alle Aktieninhaber von Gemoscan sind, sollte. Sie dafür eingewiesen Interesse aufbringen .
" disciplines.!Physiomed!is!proud!to!have!helped!improve!the!health!and!fitness!of!hundreds!of!thousands! of!Canadian "
Stormy.......2 Jahre wird's bestimmt dauern, bis wir hier mal wieder bessere Kurse sehe. !!
meine Meinung. Konzept ist nicht schlecht , aber der Erfolg Mus erst bewiesen werden !!!!
" disciplines.!Physiomed!is!proud!to!have!helped!improve!the!health!and!fitness!of!hundreds!of!thousands! of!Canadian "
Stormy
.......2 Jahre wird's bestimmt dauern, bis wir hier mal wieder bessere Kurse sehe. !! meine Meinung. Konzept ist nicht schlecht , aber der Erfolg Mus erst bewiesen werden !!!!
and fitness of hundreds of thousands of Canadian........
wenn die denen alle das Hemocode Intolerance System verkaufen, wirds ja
vielleicht doch noch etwas
Stormy
PS: Brian ist am schaffen und meinte , daß er ja auch ein Shareholder sei und mit dem Kurs nicht zufrieden ist !!
wenn die denen alle das Hemocode Intolerance System verkaufen, wirds ja
vielleicht doch noch etwas
Stormy
PS: Brian ist am schaffen und meinte , daß er ja auch ein Shareholder sei und mit dem Kurs nicht zufrieden ist !!
„Wir sehen weiterhin enormes Wertsteigerungspotenzial im Markt der paramedizinischen Kliniken. Physiomed Yorkdale, Physiomed Kennedy, das wir im August dieses Jahres erworben haben, und andere vergleichbare Unternehmen sind für Gemoscan umgehende Umsatztreiber, während sie gleichzeitig als organische Vertriebswege für unsere patentierten und proprietären, medizinisch überwachten Ernährungs- und Wellnessprogramme dienen. Physiomed Yorkdale ist ein weiterer Meilenstein auf unserem Weg, eine führende Plattform im mehrere Milliarden Dollar schweren Einzelhandel des Gesundheitswesen zu werden,“ sagte Brian Kalish, CEO von Gemoscan.
Auf Sicht von 2 Jahren besteht schon Kurs Steigerungs Potential, wenn die Zahlen das Waxhstum belegen. Na dann habe ich ja in der nächsten Zeit etwas zu beobachten
Stormy
Auf Sicht von 2 Jahren besteht schon Kurs Steigerungs Potential, wenn die Zahlen das Waxhstum belegen. Na dann habe ich ja in der nächsten Zeit etwas zu beobachten
Stormy
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -0,14 | |
| +2,70 | |
| -0,94 | |
| +1,04 | |
| -1,77 | |
| +0,92 | |
| 0,00 | |
| -0,33 | |
| +0,39 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 176 | ||
| 156 | ||
| 73 | ||
| 64 | ||
| 62 | ||
| 62 | ||
| 28 | ||
| 26 | ||
| 26 | ||
| 25 |
